Pfizer
New York, NY, USA
This posting covers multiple available positions ROLE SUMMARY TIVDAK (tisotumab vedotin-tftv) is a treatment for patients with recurrent/metastatic cervical cancer that received full FDA approval in April 2024 and launched with our co-promote partner, Genmab. This is an exciting opportunity to work on a fast-paced, co-promote with a high performing team and to support patients with advanced cervical cancer. The HCP Marketing Director is responsible for creating and developing a full promotional strategy and related tactics for TIVDAK. This role will work closely with cross-functional partners to identify tactics that advance our business objectives. This role is responsible for optimizing marketing mix, asset development, and strategic deployment across channels. As TIVDAK is co-commercialized with Genmab in the United States, the US HCP Marketing Director is responsible for leading all promotional activities and ensuring alignment across cross-functional teams...